Warning letters issued for cGMP violations, refusing entry, and falsifying documents
Regulatory NewsFerdous Al-Faruque
Audit/inspectionChemistry, Manufacturing and Controls (CMC)ComplianceGenericsPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)